Log in to search using one of your social media accounts:

 

Do you have a persistent sore throat? It could be a sign of THIS cancer
AN UNCOMMON cancer in the UK could be causing your sore throat or tiredness. (Source: Daily Express - Health)
Source: Daily Express - Health - November 20, 2017 Category: Consumer Health News Source Type: news

Medical News Today: Many grapple with PTSD after a cancer diagnosis
Researchers point to a large incidence of post-traumatic stress disorder cases at 6 months after a cancer diagnosis and urge better mental health support. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - November 20, 2017 Category: Consumer Health News Tags: Mental Health Source Type: news

Tanzania:Guidelines to Boost Cancer Treatment
[Daily News] THE much awaited National Cancer Treatment Guidelines, which are envisioned to assist the government have proper forecast of cancer medicines and other services, are in their final stages. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - November 20, 2017 Category: African Health Source Type: news

Roche announces trial successes in cancer, haemophilia
ZURICH (Reuters) - Roche announced a double dose of trial wins on Monday, saying its immunotherapy Tecentriq mixed with other drugs made advances against lung cancer, while data suggested its haemophilia agent Hemlibra could be used by more patients. (Source: Reuters: Health)
Source: Reuters: Health - November 20, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Intermittent Letrozole Similar to Continuous Administration for Extended Breast Cancer Therapy
Taking temporary treatment breaks from letrozole following endocrine therapy for breast cancer is associated with similar disease-free survival as taking letrozole continuously, according to... (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - November 20, 2017 Category: Primary Care Source Type: news

Can CEUS differentiate between IBD and colon cancer?
Is contrast-enhanced ultrasound (CEUS) effective for differentiating between...Read more on AuntMinnie.comRelated Reading: Artificial intelligence may help bridge experience gap for liver CEUS Contrast ultrasound clears up picture for renal lesions Contrast US helps assess breast cancer treatment response Contrast image processing boosts ultrasound performance What role should contrast US have for kidney lesions? (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - November 20, 2017 Category: Radiology Source Type: news

Roche says Tecentriq combination cuts lung cancer risk
ZURICH (Reuters) - A late-stage trial of Roche's immuno-oncology medicine Tecentriq with other cancer drugs as an initial therapy for lung cancer met its goal of significantly reducing the risk of disease worsening or death, the Swiss drugmaker said on Monday. (Source: Reuters: Health)
Source: Reuters: Health - November 20, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Assessment of Major Depression After Breast Cancer Assessment of Major Depression After Breast Cancer
The ability to distinguish depressive symptoms from similar cancer-related somatic symptoms in women with breast cancer remains a challenge. How best should these patients be screened and treated?Southern Medical Journal (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 20, 2017 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

Phase III IMpower150 study showed Roche ’s TECENTRIQ (atezolizumab) and Avastin (bevacizumab) plus chemotherapy significantly reduced the risk of disease worsening or death in the initial treatment of people with a type of advanced lung cancer
Roche today announced that the Phase III IMpower150 study met its co-primary endpoint of progression-free survival (PFS) and demonstrated that the combination of TECENTRIQ ® (atezolizumab) and Avastin® (bevacizumab) plus chemotherapy (paclitaxel and carboplatin) provided a statistically significant and clinically meaningful reduction in the risk of disease worsening or death (PFS) compared to Avastin plus chemotherapy in the first-line treatment of people with advan ced non-squamous non-small cell lung cancer (NSCLC). Initial observations for the co-primary endpoint of overall survival (OS) are encouraging. These d...
Source: Roche Investor Update - November 20, 2017 Category: Pharmaceuticals Source Type: news

Phase III IMpower150 study showed Roche ’s TECENTRIQ (atezolizumab) and Avastin (bevacizumab) plus chemotherapy significantly reduced the risk of disease worsening or death in the initial treatment of people with a type of advanced lung cancer
Roche today announced that the Phase III IMpower150 study met its co-primary endpoint of progression-free survival (PFS) and demonstrated that the combination of TECENTRIQ ® (atezolizumab) and Avastin® (bevacizumab) plus chemotherapy (paclitaxel and carboplatin) provided a statistically significant and clinically meaningful reduction in the risk of disease worsening or death (PFS) compared to Avastin plus chemotherapy in the first-line treatment of people with advan ced non-squamous non-small cell lung cancer (NSCLC). Initial observations for the co-primary endpoint of overall survival (OS) are encouraging. These d...
Source: Roche Media News - November 20, 2017 Category: Pharmaceuticals Source Type: news

Some cancer patients have PTSD years after diagnosis, study finds
A fifth of cancer patients experience post-traumatic stress disorder. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - November 20, 2017 Category: Consumer Health News Source Type: news

Importance of Assessing Patients' Cancer Care Experiences Importance of Assessing Patients' Cancer Care Experiences
Quality of cancer care should be considered from the patient's perspective. Review support needs that patients and caregivers experience throughout the cancer journey.Journal of Oncology Practice (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 20, 2017 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

Many cancer survivors are living with PTSD
(Wiley) A recent study showed approximately one-fifth of patients with cancer experienced post-traumatic stress disorder (PTSD) several months after diagnosis, and many of these patients continued to live with PTSD years later. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 20, 2017 Category: International Medicine & Public Health Source Type: news

FDA Approves Adjuvant Sunitinib for High-Risk RCC
The FDA has approved sunitinib (Sutent) for use as an adjuvant therapy in patients with renal cell carcinoma (RCC) who have received nephrectomy and are high risk for recurrence.11/30/2017 (Source: Kidney Cancer Association)
Source: Kidney Cancer Association - November 19, 2017 Category: Urology & Nephrology Source Type: news

Bowel cancer could soon be diagnosed by blood test
About 41,000 Britons are diagnosed with bowel cancer – a type of colorectal cancer – each year, making it the UK’s second-biggest cancer killer. (Source: the Mail online | Health)
Source: the Mail online | Health - November 19, 2017 Category: Consumer Health News Source Type: news

Health Ranger: Plants synthesize miraculous medicines at the molecular level
(Natural News) Did you know that plants naturally synthesize miracle-class medicinal molecules that can prevent and reverse disease? Corrupt governments and drug makers have long tried to convince you that only man can create “drugs” in artificial laboratories, but the simple truth is that plants have long been creating antibiotics, anti-diabetes nutrients, anti-cancer nutrients and... (Source: NaturalNews.com)
Source: NaturalNews.com - November 19, 2017 Category: Consumer Health News Source Type: news

Medical News Today: Grandparents, are you putting your grandchildren at risk of cancer?
Researchers say that grandparents should be more careful: spoiling their grandchildren and exposing them to bad habits may increase their risk of cancer. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - November 19, 2017 Category: Consumer Health News Tags: Nutrition / Diet Source Type: news

Menopause treatment is anti-ageing, says top expert
NHS England patients say they ’ve been scared by stories linking HRT with cancer, blood clots and early death – stories that are inaccurate. So what is the truth? Dr Louise Newson asks. (Source: the Mail online | Health)
Source: the Mail online | Health - November 18, 2017 Category: Consumer Health News Source Type: news

Risk of breast cancer recurrence lasts for decades
(Reuters Health) - Many women who follow initial breast cancer treatment with five years of hormone therapy to keep tumors at bay may still experience new malignancies up to two decades after their diagnosis, a study suggests. (Source: Reuters: Health)
Source: Reuters: Health - November 17, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

J & J Wins California Lawsuit Claiming Asbestos in Talc Caused Cancer J & J Wins California Lawsuit Claiming Asbestos in Talc Caused Cancer
A California jury on Thursday ruled in favor of Johnson& Johnson in a lawsuit by a woman who said she developed the cancer mesothelioma after being exposed to asbestos in the company's talc-based products including J&J's Baby Powder.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 17, 2017 Category: Consumer Health News Tags: Medscape Today News Source Type: news

PET Imaging May Predict Drug Response, Survival in Advanced Prostate Cancer PET Imaging May Predict Drug Response, Survival in Advanced Prostate Cancer
Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 17, 2017 Category: Consumer Health News Tags: Medscape Today News Source Type: news

Pfizer, Novartis Agree UK Price Cuts for New Breast Cancer Drugs Pfizer, Novartis Agree UK Price Cuts for New Breast Cancer Drugs
Pfizer and Novartis have agreed price cuts for their rival breast cancer drugs Ibrance (palbociclib) and Kisqali (ribociclib) to ensure they can be used routinely within Britain's state-funded health service.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 17, 2017 Category: Consumer Health News Tags: Medscape Today News Source Type: news

Prostate Cancer Care Is'Changing Rapidly': ESMO 2017 Prostate Cancer Care Is'Changing Rapidly': ESMO 2017
Exciting research presented at ESMO 2017 will likely affect clinical practice in metastatic prostate cancer, says Dr Johann de Bono.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - November 17, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

General practitioners accurately diagnose DVT with US
General practitioners can be trained in compression ultrasonography to accurately...Read more on AuntMinnie.comRelated Reading: Role of imaging modalities is changing for PE diagnosis Ultrasound elevates diagnosis of pulmonary embolism Can ultrasound for deep vein thrombosis cause a PE? Ultrasound screening catches embolism in cancer patients AAOS includes DVT US on Choosing Wisely list (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - November 17, 2017 Category: Radiology Source Type: news

I Survived 8 Cancer Battles. Here Are 5 Life Lessons I Learned
1. Know your family history (Source: Healthy Living - The Huffington Post)
Source: Healthy Living - The Huffington Post - November 17, 2017 Category: Consumer Health News Source Type: news

A Bill to'Eliminate Prostate Cancer Misdiagnosis'A Bill to'Eliminate Prostate Cancer Misdiagnosis '
Who wouldn't want to eliminate the problem of men being wrongly told they had prostate cancer?Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 17, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Optimizing Treatment for Castration-Resistant Prostate Cancer Optimizing Treatment for Castration-Resistant Prostate Cancer
Individualizing castration-resistant prostate cancer therapy depends not only on drug profiles but also on patient-related factors. Experts offer a way through the data to reach a clinical decision.Medscape Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 17, 2017 Category: Consumer Health News Tags: Hematology-Oncology Commentary Source Type: news

I Lost My Mom During My First Pregnancy
As the cancer progressed, it became clear to me that she would pass away before the baby arrived. (Source: Healthy Living - The Huffington Post)
Source: Healthy Living - The Huffington Post - November 17, 2017 Category: Consumer Health News Source Type: news

Sabga Foundation pledges $1M toward TGen pancreatic cancer research
(Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - November 17, 2017 Category: American Health Authors: Angela Gonzales Source Type: news

Erlotinib Overdose Tied to Conjunctivitis
Findings in case study of man being treated for non - small - cell lung cancer (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - November 17, 2017 Category: Cancer & Oncology Tags: Family Medicine, Internal Medicine, Emergency Medicine, Oncology, Ophthalmology, Pharmacy, Journal, Source Type: news

7 medtech stories we missed this week: Nov. 17, 2017
[Image from unsplash.com]From Skyline Medical’s joint venture to Lensar receiving FDA clearance and CE Mark, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. Skyline Medical launches JV deal with Helomics Skyline Medical announced in a Nov. 15 press release that it has signed a joint venture agreement with Helomics. The agreement comes after a strategic collaboration between the companies that allows Skyline to reach more markets. The joint venture leverages the Helomics D-Chip platform to develop and market new approaches for personalized cancer diagnostics and care. 2.&...
Source: Mass Device - November 17, 2017 Category: Medical Devices Authors: Danielle Kirsh Tags: 510(k) Diagnostics Food & Drug Administration (FDA) mHealth (Mobile Health) Neurological Neuromodulation/Neurostimulation Regenerative Medicine Regulatory/Compliance Research & Development Helomics InnerScope iReliev LensAR Inc. Source Type: news

Lab-Grown Mini Organs Could Speed Up Drug Discovery
Mini organs grown in the laboratory could lead to quicker discovery and evaluation of new drugs for many diseases, including cancer. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - November 17, 2017 Category: Pharmaceuticals Authors: Victoria Forster, Contributor Source Type: news

Public health data to be shifted to NHS 'safe haven'
Public Health England could move potentially millions of patients’ personal data to an NHS “safe haven” – but will likely retain control of the cancer registry for now, the Department of Health has said. (Source: HSJ)
Source: HSJ - November 17, 2017 Category: UK Health Source Type: news

Negligible Benefit Of Nerlynx, A New Breast Cancer Drug, Calls For Caution
The question for patients with early-stage HER2+ breast cancer is if it ’s worth taking a treatment (Nerlynx) that lowers the risk of distant recurrence by less than 2% at 5 years, and which has not yet been studied over the long term. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - November 17, 2017 Category: Pharmaceuticals Authors: Elaine Schattner, Contributor Tags: NASDAQ:PBYI VTX:ROG Source Type: news

‘Barcoding’ Cells in Nematodes Could Bring Advances and New Medical Laboratory Tools for Treatment of Cancer and Other Chronic Diseases
Ongoing research at the University of Washington promises new methods for identifying and cataloging large numbers of cells quickly, which could lead to more individualized treatments in support of precision medicine initiatives Researchers have found a new method for identifying specific cell types by groups, a breakthrough that some experts say could lead to new […] (Source: Dark Daily)
Source: Dark Daily - November 17, 2017 Category: Laboratory Medicine Authors: Jude Tags: Laboratory Instruments & Laboratory Equipment Laboratory Management and Operations Laboratory News Laboratory Operations Laboratory Pathology Laboratory Testing Management & Operations anatomic pathology Aviv Regev PhD Broad Institute Source Type: news

Novartis, ASCP and ACS join forces to fight cancer in Ethiopia, Uganda and Tanzania
Novartis, the American Society for Clinical Pathology (ASCP) and the American Cancer Society (ACS) will work together to devise a common approach to improve access to cancer treatment in Sub-Saharan Africa. Each partner brings unique expertise in cancer diagnosis and treatment. This complements the work the Clinton Health Access Initiative (CHAI) is doing to improve access to affordable, quality-approved oncology medicines in the region. (Source: World Pharma News)
Source: World Pharma News - November 17, 2017 Category: Pharmaceuticals Tags: Featured Novartis Business and Industry Source Type: news

Gut microbiome influences efficacy of PD-1based immunotherapy against epithelial tumors
This piece of research is behind the headline: Gut bacteria " boost " cancer therapy. This early-stage study gives us some insights into factors that might influence people's responses to a specific type of cancer treatment (immunotherapy with monoclonal antibodies). The findings are of interest, but don't have any immediate implications for cancer treatment. This early-stage study gives us some insights into factors that might influence people's responses to a specific type of cancer treatment (immunotherapy with monoclonal antibodies).The findings are of interest, but don't have any immediate implications for c...
Source: Current Awareness Service for Health (CASH) - November 17, 2017 Category: Consumer Health News Source Type: news

Boy with incurable cancer aims to complete his bucket list
Toby Davis, eight, from Byfleet, Surrey, was diagnosed with rhabdomyosarcoma, a rare cancer of the soft tissue cells, in October 2016 and his parents, were told it was incurable. (Source: the Mail online | Health)
Source: the Mail online | Health - November 17, 2017 Category: Consumer Health News Source Type: news

The breast cancer symptoms that weren't lumps
EXCLUSIVE: Mothers Emily Nunn, 40, from Rotherham, South Yorkshire, and Katherine Vesey, 42, from the Wirral, Merseyside, first experienced (Source: the Mail online | Health)
Source: the Mail online | Health - November 17, 2017 Category: Consumer Health News Source Type: news

Bayer and Loxo Oncology to develop and commercialize two novel oncology therapies selectively targeting genetic drivers of cancer
Bayer has entered into an exclusive global collaboration with Loxo Oncology, Inc., a biopharmaceutical company based in Stamford, Connecticut, US, (NASDAQ: LOXO) for the development and commercialization of larotrectinib (LOXO-101) and LOXO-195. Both compounds are being investigated in global studies for the treatment of patients with cancers harboring tropomyosin receptor kinase (TRK) gene fusions, (Source: World Pharma News)
Source: World Pharma News - November 17, 2017 Category: Pharmaceuticals Tags: Featured Bayer Business and Industry Source Type: news

Medical News Today: Existing parasite drug may fight prostate, colon cancer
Researchers are testing the potential of a known antiparasite drug in the treatment of colon and prostate cancer. The drug can inhibit cancer cell growth. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - November 17, 2017 Category: Consumer Health News Tags: Prostate / Prostate Cancer Source Type: news

Lung Cancer
(Source: eMedicineHealth.com)
Source: eMedicineHealth.com - November 17, 2017 Category: General Medicine Source Type: news

Thyroid Cancer
(Source: eMedicineHealth.com)
Source: eMedicineHealth.com - November 17, 2017 Category: General Medicine Source Type: news

Can AI diagnose pneumonia better than radiologists?
An artificial intelligence (AI) algorithm developed by Stanford University...Read more on AuntMinnie.comRelated Reading: Deep learning shows promise for bone age assessment Chest doctors issue guidelines for CT lung cancer screening AI algorithm predicts lung disease, adverse events on CT NIH opens massive x-ray database to propel AI research NIH releases massive database of chest x-rays (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - November 17, 2017 Category: Radiology Source Type: news

Circulating Vitamin D Concentration and Risk of Seven Cancers Circulating Vitamin D Concentration and Risk of Seven Cancers
Using a comprehensive Mendelian randomization study, the authors sought to determine whether there is a linear association between vitamin D status and cancer risk.The BMJ (formerly known as the British Medical Journal) (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 17, 2017 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

Study analyzes mutations in cerebrospinal fluid in lung cancer with brain metastases
(European Society for Medical Oncology) Researchers have explored the analysis of mutations in cerebrospinal fluid of lung cancer patients with brain metastases in a study presented at the ESMO Asia 2017 Congress. Tumor tissue from brain metastasis is difficult to obtain and therefore less invasive methods are needed to identify and monitor the presence of known actionable mutations. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 17, 2017 Category: Cancer & Oncology Source Type: news

Anti-tumor and Immune-potentiating Enterococcus faecalis-2001 & #946;-glucans
(Bentham Science Publishers) Background: Enterococcus faecalis 2001 is a probiotic lactic acid bacterium and has been used as a biological response modifier (BRM). From physiological limitation of bacterial preservation in storage and safety, the live E. faecalis 2001 has been heat-treated and the BRM components containing high level ofβ-glucan, named EF-2001, were prepared. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 17, 2017 Category: Cancer & Oncology Source Type: news

Link between obesity and cancer is not widely recognized
(Oxford University Press USA) A new study published in the Journal of Public Health has shown that the majority of people in the United Kingdom do not understand the connection between weight issues and cancer. Obesity is associated with thirteen types of cancer, including those of the breast, kidney, bowel, and womb. However, after surveying 3293 adults, taken as representative of the UK population, researchers found that only a quarter of respondents were aware of the link between obesity and cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 17, 2017 Category: Cancer & Oncology Source Type: news

Novel therapeutic target discovered for estrogen receptor positive (ER+) breast cancer
(The Mount Sinai Hospital / Mount Sinai School of Medicine) Mount Sinai researchers identify new protein in a common subtype of breast cancer which can potentially offer more effective therapies for the future. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 17, 2017 Category: Cancer & Oncology Source Type: news

How a poorly explored immune cell may impact cancer immunity and immunotherapy
(Michigan Medicine - University of Michigan) The immune cells that are trained to fight off the body's invaders can become defective. It's what allows cancer to develop. So most research has targeted these co-called effector T-cells. But a new study takes a step back and considers: What if the problem isn't with the effector T-cells but starts higher up the cellular chain? (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 17, 2017 Category: Cancer & Oncology Source Type: news